CP
MRK icon

Creekside Partners’s Merck MRK Stock Holding History

Creekside Partners’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$244K Buy
2,028
+2
+0.1% +$231 0.1% 162
2025
Q4 		$213K Buy
+2,026
New +$190K 0.09% 175
2024
Q4 		– Sell
-2,007
Closed -$228K – 167
2024
Q3 		$228K Sell
2,007
-48
-2% -$5.7K 0.12% 156
2024
Q2 		$254K Buy
+2,055
New +$265K 0.14% 138

Other funds holding MRK

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Creekside Partners's MRK Position: Q1 2026 in Review

Creekside Partners increased its Merck (MRK) stake by 0.1% in Q1 2026, buying an estimated $231 and bringing the position to 2,028 shares worth $244K. The position accounts for 0.1% of the portfolio, ranked #162.

Creekside Partners first reported a position in MRK in Q2 2024 and has held it in 4 quarters since. The position peaked at $254K in Q2 2024. 3,779 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Creekside Partners held 2,028 shares of Merck worth $244K as of Q1 2026.
  • Creekside Partners bought 2 Merck shares in Q1 2026, an estimated $231.
  • Merck made up 0.1% of Creekside Partners's portfolio in Q1 2026, its #162 holding.
  • Creekside Partners first reported a position in Merck in Q2 2024 and has held it in 4 quarters since.
  • Creekside Partners's Merck position peaked at $254K in Q2 2024.
  • 3,779 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Creekside Partners's 13F filing for Q1 2026, filed 22 Apr 2026.